Equable Ivf Europe LP is a private equity fund based in New York, New York. Its most recent Form D, filed Nov 13, 2024, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Jonathan Smidt.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Jonathan Smidt
- Latest Form D
- Nov 13, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Equable Ivf Europe LP
What is the minimum investment for Equable Ivf Europe LP?
Equable Ivf Europe LP's latest Form D, filed Nov 13, 2024, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Equable Ivf Europe LP?
Equable Ivf Europe LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Equable Ivf Europe LP raised?
Equable Ivf Europe LP's latest Form D, filed Nov 13, 2024, reports no sales yet.
Where is Equable Ivf Europe LP based?
Equable Ivf Europe LP is based in New York, New York.
Size compared with every private equity fund
This fund hasn't reported any sales yet.